1. Introduction
Animal toxins are molecules selected from thousands of years of evolution. Some of their properties are quite impressive when considering some aspects, such as the amount of venom injected into the prey or victim, and the specificity of their effects, including hemostasis, cardiovascular system, and central nervous system. Some of the molecules and effects have been used as templates for the development of new drugs, such as Captopril and Ziconotide, for example. The effects on the central nervous system are more impressive if we consider that the molecules must be resistant to plasmatic enzymes and need to cross the blood–brain barrier. Some venom of snakes, scorpions, and spiders exhibit the capability to elicit potent effects on the CNS, including the death of the prey/victim. Some of the effects of the armed spider
Phoneutria nigriventer relating to the peripheral and central nervous system have been described, but some effects clinically described in accidents were lacking, in particular when we refer to changes in the thermic regulation of the body observed in mammals and also in some clinical cases in humans [
1]. Some toxins from
Phoneutria nigriventer showed effects related to calcium and ion channels, revealing effects such as flaccid paralysis, penile erection, and hypersalivation [
1,
2], but no studies on body temperature have been performed even in clinical reports where variations in body temperature were described in the literature. This phenomenon and its mechanism remain totally unclear; instead, its relevance to homeostasis and physiological functions has been discussed. The main thermal effects and alterations were related to inflammatory mediators and, in some cases, could be related to specific diseases such as malignant hypertension or cerebral tumors [
3]. Envenoming with
Phoneutria nigriventer displays less significant inflammatory symptoms, suggesting another putative pathway to the body temperature alterations. Clinically, there is much evidence that
Phoneutria nigriventer toxins, besides other observed effects, could act in thermoregulation parameters.
There are several studies characterizing the fractions of
Phoneutria nigriventer venom.
Phoneutria nigriventer venom has three main described neurotoxic fractions (PhTx1, PhTx2, and PhTx3), with PhTx1 and PhTx2 causing tail elevation in experimental animals, agitation, and spastic paralysis of the posterior train. PhTx2 also causes salivation, tearing, priapism, convulsions, and spastic paralysis of the anterior train, and PhTx3 causes only flaccid paralysis of the limbs [
4,
5].
Regarding clinical aspects, Antunes and Malaque [
5] described phoneutrism as presenting predominantly local symptoms, with a systemic condition occurring mainly in children. In general, symptoms vary in degree and are classified as mild, moderate, and severe, with manifestations ranging from pain, edema, erythema, and sweating in the area of the bite to profuse vomiting, priapism, diarrhea, bradycardia, hypotension, cardiac arrhythmia, acute pulmonary edema, and shock. In the systemic context, among other symptoms, generalized sweating is observed in accidents of moderate to severe intensity. In a survey carried out between 1989 and 1998, systemic changes with the presence of sweating occurred in 7.5% of cases, with a prevalence in young people over 15 years of age [
4].
Therefore,
Phoneutria venom produces hemodynamic changes of central and peripheral origin. The central component appears to be mediated by the activation of cardiovascular centers, causing increased sympathetic discharge in the periphery, while the peripheral component appears to result from the direct activation of vascular adrenoceptors and/or release of catecholamines from sympathetic nerve endings [
5].
In this work, we tested the effects of crude and purified Phoneutria nigriventer venom fractions on the body temperature and tested if the effects are related to inflammatory pathway or not, using regular clinical anti-thermal compounds.
3. Discussion
Among venomous species involved in accidents with humans in Brazil,
Phoneutria nigriventer and
Tityus serrulatus are responsible for most of the accidents. The clinical manifestations of accidents caused by
Phoneutria nigriventer indicate central and peripheral actions [
6]. Among several manifestations are pain, vomiting, tachycardia, hypotension, hypertension, arrhythmia, sweating, and tremors [
4,
6,
7]. Arthropod venoms are a rich source of compounds and small active molecules with effects that remain undiscovered [
8].
Phoneutria nigriventer venom is composed of several components [
9] that act on channels of neuronal importance, such as sodium, calcium, and potassium channels. Gomez and collaborators (2002) quantified seventeen active peptides with functions involving ion channels and receptors [
6] with weights between 3500 and 9000 Da; symptoms also include tremors and sweating, which are symptoms linked to thermoregulation. The venom of
Phoneutria nigriventer, also acts on channels of neuronal importance, in this case, voltage-dependent sodium and potassium channels [
10].
Therefore, it is possible to see that the symptoms described after accidents with
Phoneutria nigriventer may also have different symptoms, and some researchers may describe them as antagonistic. These symptoms include hypotension and hypertension or hypothermia and hyperthermia [
4,
6,
11]. Therefore, this work aims to evaluate the activity of the total venom of
Phoneutria nigriventer and their isolated fractions in relation to variations in the body temperature of rats.
The aforementioned antagonistic effects can also be seen in tests carried out with animals treated with crude venom and purified fractions. Animals treated with the crude venom showed both hypothermic and hyperthermic action. Data obtained using the crude venom of
Phoneutria nigriventer [
12] showed a mainly hypothermic action in rats. The fractionation of the venom resulted in fractions containing molecules of different molecular weights, as expected, as it is a molecular exclusion chromatography, where high molecular weight molecules are eluted first, followed by medium [
4,
6,
11] molecular weight molecules and the last molecules to be eluted are those of low molecular weight. Thus, pool I of
Phoneutria nigriventer venom showed bands between 80 and 40 kDa and some less evident bands below 40 kDa. Pool II showed molecules with a molecular weight below 30 kDa, and pools III and IV showed molecules with a molecular weight between 30 and 20 kDa.
In order to study the obtained fractions activities on thermoregulation, the pools were tested in vivo, and it was possible to observe that pool II of
Phoneutria nigriventer venom caused a decrease in body temperature in rats from the second hour of the experiment. However, pool III showed hyperthermic activity from the second hour onwards, but this did not maintain the increase in body temperature as pool II continued to maintain hypothermic activity. Therefore, the activity of pool III was more easily controlled by the rat organism than pool II. Studies show that accidents with
Phoneutria nigriventer can cause, in some cases, tremors and/or sweating, highlighting the antagonistic effect of this venom [
4,
6,
7]. This corroborates the data obtained in this work, where pool III caused hyperthermia and pool II hypothermia.
Therefore, in order to identify the possible components responsible for the activity on thermoregulation, the active pools were purified and tested in vivo. In this purification stage, it was possible to observe that pool II of
Phoneutria nigriventer, with hypothermic action, presented a chromatogram containing 32 peaks. However, 6 of these 32 were chosen for in vivo tests, due to the peak yield, but none of these chosen was responsible for the hypothermic activity, presented by pool II. Although none of the chosen peaks showed hypothermic activity, peaks 8 and 13 were responsible for a significant increase in the rats’ body temperature in the third hour of the experiment in relation to control animals. Among the peaks chosen, peak 8 was the one with the lowest intensity, so it was only possible to attempt identification by mass spectrometry. Peak 13 was subjected to cell viability assessment using the MTT colorimetric method using human glioblastoma cells (U87) (
Supplementary Material), as it is described that the venoms of these arthropods have many neurotoxins, that is, they have action on the cells of the nervous system [
11]. Sueur and collaborators [
13] also tested
Phoneutria nigriventer venom in cell culture for viability, and these tests were carried out on three different cell types of neuronal origin: ECV304 endothelial, C6 glioma, and epithelial MDCK, showing that there was a small decrease in the viability of cells of the C6 glioma lineage, without interference in the other lineages [
13].
Thus, as peak 13 is responsible for increasing body temperature, it was also tested together with the medication for malignant hyperthermia, Dantrolene. Malignant hyperthermia is a genetic disease in which the patient’s body temperature increases when subjected to some types of inhalational anesthetics such as halothane, isoflurane, or succinylcholine [
14]. It is known that Dantrolene acts by blocking RYR1 and RYR3 type calcium channels, present in skeletal muscle and other tissues, including the brain, respectively [
15]. Since
Phoneutria nigriventer neurotoxins act on channels of neurological importance and also on the release of neurotransmitters in synaptic clefts [
5,
16], the synergism of this medicine with this peak isolated from
Phoneutria nigriventer venom could assist in the study of this molecule. However, tests regarding the joint action of peak 13 with Dantrolene did not show significant results. Being a medicine for malignant hyperthermia and also a muscle relaxant, the expected result was that the temperature would drop in the group of animals treated only with the medicine; however, this was not the case. It is known that Dantrolene acts on specific calcium channels, receptors other than ryanodine, and these types of channels may have different locations and concentrations in humans and rats [
15]. This could be a plausible explanation for these non-significant results, as well as the fact that the disease malignant hyperthermia is related to several genetic mutations, and the majority are associated with chromosome 19, the gene for the ryanodine receptor RYR1 [
17,
18]. As animals do not have the disease malignant hyperthermia, they may simply not have the ryanodine receptor modified to interact with the active ingredient of Dantrolene, which could be an explanation for the absence of effects in normal rats.
Tachykininins have widespread pharmacological actions, acting on the central nervous, cardiovascular, genitourinary, respiratory and gastrointestinal systems. Peptides from this group were found mammalian tissue and also in amphibian gut and insects and the main peptides were Substance P, neurokinin A and B having three identified re-ceptors NK1, NK2 and NK3 [
19,
20]. Substance P and related tachykinins have significant actions on the central nervous system particularly in brain injury [
21]. Compounds of the Ctenotoxin family are described as the ctenotoxin U13-CNTX-Pn1a acting, according to the Swiss/Prot database, probably also as a neurotoxin and U19-CNTX-Pn1a is non toxic to mice and insects [
22]. In order to identify which molecule was present in peak 13, it was necessary to analyze these peaks by mass spectrometry. As a result of this analysis, masses similar to molecules already described were obtained from the Tachykinin and Ctenotoxin families, mainly of the Pn1a type. These molecules are being studied and it is known that tachykinins have widespread pharmacological actions, acting on the central nervous, cardiovascular, genitourinary, respiratory and gastrointestinal systems. The compounds of the Ctenotoxin family are described as the ctenotoxin U13-CNTX-Pn1a acting, according to the Swiss/Prot database, probably as a neurotoxin and U19-CNTX-Pn1a is not toxic to mice and insects [
22]. Both are neurotoxins produced by the species
Phoneutria nigriventer [
1,
23,
24].
Just as pool II of
Phoneutria nigriventer venom was responsible for hypothermic activity, pool III also demonstrated hyperthermic activity. So, now analyzing the results for pool III, it can be seen that its peaks 30 and 31 increase the temperature in animals, while its peak 28/29 decreases body temperature in rats. Pool III of
Phoneutria nigriventer spider venom showed hyperthermic activity; however, one of the peaks from this pool tested in bioassay decreased the temperature in rats. Once again, the results show that the venom has molecules with antagonistic actions [
6]. These observed effects could be mediated by a pro-inflammatory action in the central nervous system [
25,
26,
27].
In this way, the peaks from tested pool III and that showed activity on body tem-perature in rats were repurified to proceed to the next step, which involved the use of LPS from E. coli bacteria. The three peaks 28/29, 30, and 31, were not very pure, which is why the peaks were repurified. After separation, these subpeaks were tested again to find out which activity(ies) were concentrated. Subpeak 28/29, with hypothermic action, generated three more peaks, and peaks 30 and 31 generated two peaks each (29a, 29b, 29c, 30a, 30b, 31a, and 31b). Of the three peaks belonging to peak 28/29, the one (s) that showed hypo-thermic activity would be tested together with LPS to verify whether one mechanism of action would interfere with the other; however, none of the three peaks showed the expected activity. The venom has many molecules, and these can interact with each other to have a satisfactory effect on the state of poisoning. Scorpion venom is a good example, with alpha and beta neurotoxins acting together [
16].
Of these seven repurified peaks tested in vivo, only peak 30b, due to yield, was subjected to amino acid sequencing by Edman degradation. The remaining peaks will be sequenced in future work. Peak 30b, despite not having shown activity on the body temperature of animals, was previously selected to be sequenced, considering the neurotoxin Tx2-6. This neurotoxin acts mainly by decreasing the inactivation of sodium channels [
28,
29,
30] and can also cause, in rats, piloerection and tremors [
30], which are responses controlled by thermoregulation [
31].
Interestingly, Leite and collaborators (2012) also carried out tests with the brain, lung, and heart tissue of animals treated with this neurotoxin and described that the brain tissue was the least affected [
29]. The lungs showed vascular congestion and alveolar hemorrhage, and the heart showed hemorrhage in the sub-endothelial tissue. The peaks 29, 30, and 31 were tested in cultured hypothalamus neurobasal cells; all the peaks showed a statistically significant decrease in cell viability at lower concentrations after 24 h of incubation. At 6 h of incubation, the statistics showed that the peaks 30 and 31 increased the viability of cells in higher concentrations. Before repurifying peaks 28/29, 30 and 31, cell viability tests were performed in neuro-basal cell culture. All peaks decreased cell viability of these cultures at low concentrations after 24 h of incubation (
Figures S8–S10). The animals treated by Leite et al. [
29] were injected with a concentration 8× higher than those treated in the present work. Our data also showed that after the 6-h incubation period, peaks 30 and 31 at higher concentrations were positively significant for cell culture (
Figures S4–S7) [
32].
5. Materials and Methods
5.1. Animals
The project was approved by the Committee on Ethics in the Use of Animals of Instituto Butantan (CEUAIB) under protocol number 869/11.
In the present study, male Wistar–Han heterogenic albino rats (Rattus norvegicus) of conventional controlled sanitary status, weighing approximately 180 g, were obtained from the Central Biotério of the Butantan Institute and maintained at the Laboratory of Biochemistry and Biophysics Laboratory. These animals were housed in ventilated shelves in groups of 4 to 6 rats per polypropylene cage (49 × 34 × 16 mm) with a carved bed of Pinnus sp., Autoclaved. Within 2 or 3 days, the animals were used for the experimentation described later in this study. The animals were fed commercially specific feed (Nuvilab CR1-Nuvital), autoclaved, and filtered water; both supplied “ad libitum”, and kept in an environment with a photoperiod of 12/12 h light/darkness controlled by L & D timer.
5.2. Venom
Venom from spiders (Phoneutria nigriventer) were supplied by the Venom Section of the Scientific Development Division of the Butantan Institute in lyophilized form, ranging from 50 to 60 mg per batch, and were stored in a freezer (−20 °C).
5.3. Gel Filtration of Venom from Phoneutria nigriventer
The venom was diluted in a 2% acetic acid elution solution. After dilution, the venom was centrifuged for 30 min at 955 g in a MIKRO 200R Hettich Zentrifugen centrifuge. The supernatant was removed, and the precipitate was discarded. This step was repeated for another two or three times, totaling a volume of 1.5 mL at the end. The venom was applied to a glass column (74 × 2 cm) filled with Sephadex G-50M resin (Sigma, St. Louis, MO, USA). The run flow was maintained at 200 μL/min. The fractions were collected with the aid of a model collector type 2110 fraction collector Bio-Rad® (South Granville, Australia), every 1.5 mL. After the collection, all the tubes were read in a spectrophotometer, Pharmacia Biotech, Ultrospec 2000, UV/visible spectrophotometer, with a wavelength of 280 nm. The concentrations of the samples were calculated through the refractive indices. All fractions collected were grouped according to the graph obtained by the optical density reading. The samples were lyophilized and stored in a freezer at −20 °C.
5.4. High-Performance Liquid Chromatography (HPLC) of the Active Fractions of Phoneutria nigriventer Venom
According to in vivo assays, the fractions (pools) that showed activity were purified by high-performance liquid chromatography (HPLC-Shimadzu 10-A, ClassVP software 5.0), using a C18 reverse phase column (LiChroCart 250-4 µm 250 mm × 46 mm), monitored by a variable UV detector set at 214 nm. The following solutions were used for elution: (A) 0.1% TFA (trifluoroacetic acid) (MERCK, Darmstadt, Germany) in ultrapure water; (B) 10% mobile phase A in acetonitrile.
The Phoneutria nigriventer venom pools obtained through gel filtration were purified in HPLC using a gradient from 5 to 100% of solution B in 45 min, at a flow rate of 1 mL per minute with the elution solutions (mobile phase) already described peaks were collected, lyophilized and stored at −20 °C.
5.5. Evaluation of the Activity of Phoneutria nigriventer Venom on Rat Body Temperature Variation
5.5.1. Effects of Crude Venom
To evaluate the effect of total venom on body temperature variation, we used six animals treated with 600 μg/kg (IP) of crude venom from Phoneutria nigriventer. A control group received saline (0.2 mL, IP) under identical conditions. Animals were anesthetized with ketamine hydrochloride (25 mg/kg) and xylazine hydrochloride (10 mg/kg) intraperitoneally. A temperature sensor (ML 309 Thermistor Pod-°C Scale-AdInstruments®) was inserted subcutaneously into the back of the neck and connected to recording software (Lab Chart Powerlab-Windows 8.1.30). After 30 min of anesthesia, an intraperitoneal sub-lethal dose of the venom was administered. Controls were conducted seasonally with three or four animals every 1.5 months to account for annual basal temperature variations in normothermic animals. Body temperature was monitored every 5 min for 3 h.
5.5.2. Effects of Venom Pools
After obtaining the venom pools of Phoneutria nigriventer, five groups containing five to nine animals each were established. The treated groups received 600 μg/kg (IP) of the venom pools, while the control groups received saline (0.2 mL, IP). The surgical procedure and the equipment used were the same as described previously.
5.5.3. Effects of HPLC Venom Peaks
After identifying the pools that showed activity on body temperature variation, these were purified by chromatography (HPLC). The resulting peaks were collected and tested for activity. Six groups containing three to six animals each were established for peaks from one pool, with a control group of four animals. For the second pool, five groups of six to eight animals each were established, with a control group of five animals. All animals were treated with 100 μg/kg (IP) of the peaks, while control groups received saline.
5.5.4. Effects after Treatment with Dantrolene
To further evaluate the hyperthermic peak’s activity, the drug Dantrolene (Sigma Aldrich) was tested in conjunction with this peak. Using the same method described previously, Dantrolene (10 mg/kg, IP) was first tested in a group of five animals. Subsequently, a group of three animals was treated with both Dantrolene (10 mg/kg) and the hyperthermic peak from Phoneutria nigriventer venom. Both treatments were administered 30 min after anesthesia.
5.5.5. Effects after Repurification of Peaks from Pool III
After identifying the peaks from pool III that showed activity on body temperature variation, these were repurified by chromatography (HPLC). Seven groups were established for the repurified peaks 29a, 29b, 29c, 30a, 30b, 31a, and 31b, each containing three to five animals and a control group of five animals. All animals were treated with 100 μg/kg (IP) of the repurified peaks, while control groups received saline.
5.6. Identification by Mass Spectrometry of the Venom Peaks of Phoneutria nigriventer with Action on Thermoregulation
After identifying the peaks that showed some activity on the body temperature variation, they were submitted to identification using mass spectrometry by Dr. Daniel Carvalho Pimenta in the laboratory of Biochemistry and Biophysics of the Butantan Institute, in an ESI-IT- Tof (Shimadzu Co., Kyoto, Japan) spectrometer. The samples were diluted in 50% acetonitrile in water containing 0.5% formic acid and injected directly into the mass spectrometer by hand injection in a Rheodyne injector, positive mode, with a flow of 50 μL/min, in the same solution used in the dilution of the samples. The voltage of the interface used was 4.5 kV, and the voltage of the detector was 1.76 kV, with a temperature of 200 °C. The fragmentation was by argon collision gas, with 50% of energy, and the spectra were obtained in the range of 50 to 200 m/z. The data obtained were analyzed by LC-MS solution software 2.7.0 (Shimadzu Co.,Kyoto, Japan) and compared with the UniProtKB/Swiss-Prot database of venom proteins from Phoneutria nigriventer for identification.
5.7. Peptide Sequencing by Edman Degradation
For identification of pool III peak 30b, it was subjected to Edman degradation sequencing (Edman, 1950), as follows: 15 μL of the sample were applied to a glass fiber membrane treated with trifluoroacetic acid (TFA) (Wako), and its N-terminal end was sequenced by Edman degradation in a Shimadzu PPSQ-21 automatic protein sequencer (Shimadzu Co., Kyoto, Japan) following the manufacturer’s instructions. The Edman degradation technique consists primarily of the coupling of the peptide with the phenylisothiocyanate (PITC) reagent with the addition of pyridine to alkaline conditions, in which PITC reacts with the N-amino terminal residue to form N-phenylthiocarbamoyl (PTC). Under acidic conditions with the addition of TFA, a molecular rearrangement takes place in which the first peptide bond is cleaved, and, thus, the formation of anilinothiazolinone (ATZ) and the remainder of the peptide without the first amino acid. Still in a dilute acid medium, ATZ is converted to a more stable form in the form of phenylthiohydantoin (PTH). The quantification and identification of the samples are performed by comparing them with the standard analyzed at the start of the sequencing.
5.8. Statistical Analysis
Data related to body temperature variation tests were statistically analyzed using GraphPad Prism5 software. The test used was a T-test, and the data were analyzed every fifteen minutes, comparing the control group with the experimental groups.